Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors.
Lee, J., Choi, H., Kim, K.H., Jeong, S., Park, J.W., Baek, C.S., Lee, S.H.(2008) Bioorg Med Chem Lett 18: 2292-2295
- PubMed: 18353638 
- DOI: https://doi.org/10.1016/j.bmcl.2008.03.002
- Primary Citation of Related Structures:  
2R64 - PubMed Abstract: 
A novel series of 3,5-diaminoindazoles were prepared and found to be CDK inhibitors. Potent inhibitors against CDK1 and CDK2 were obtained by introduction of 1lambda(6)-isothiazolidine-1,1-dioxide at 5-position of indazole. Anti-proliferative activities of compounds were evaluated using EJ, HCT116, SW620, and A549 cancer cell lines.
Organizational Affiliation: 
Department of Chemistry, Keimyung University, 1000 Sindang-Dong, Dalseo-Gu, Daegu 704-701, South Korea. jinho@kmu.ac.kr